Palantir Technologies Inc.'s 30% dip signals a buying opportunity amid growth in AI investments and defense spending. Click ...
NHS chief data and analytics officers are worried about the way NHS England is running its Federated Data Platform programme.
In healthcare we trust—or do we? A breakdown in trust, like the schism in the transatlantic alliance, should make us think again about whether the current model requires reinvention. An anonymous ...
The data analysis and surveillance company is the darling of Wall Street for its use of artificial intelligence in defense ...
Palantir (NASDAQ: PLTR) has been one of the stock market's biggest success stories over the last two years. Shares of the AI ...
FireHawk Bioherbicide, the breakthrough environmentally friendly weed killer that works fast while improving soil health, is set to make a bold impact at the National Hardware Show (NHS) in Las Vegas, ...
The Palantir share price has bombed over the past week or so, leaving this writer wondering if now's the time to snap up this ...
Palantir's growth has been soaring in the U.S., but the defense tech company's growth in Europe is plateauing. Its overseas struggles could exacerbate other risks for the stock. Shares of the AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results